Rochester, Minnesota Clinical Trials

A listing of Rochester, Minnesota clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 49 clinical trials
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

This is a Phase Ib/II study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia (ALL).

Mayo Clinic
 (1.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +29 other locations
None

Mayo Clinic Rochester
 (1.8 away) Contact site
  • 0 views
  • 19 May, 2025
  • +19 other locations
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

dementia
aphasia
pick's disease
progranulin
Mayo Comprehensive Cancer Center - PPDS
 (1.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +46 other locations
Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

This early phase I trial studies the feasibility of giving memantine for the reduction of cognitive impairment after radiation therapy in pediatric patients with central nervous system tumors. Memantine may reduce the effects of radiation therapy on memory and thinking.

cognitive impairment
memantine
direct bilirubin
cancer
effects of radiation therapy
Mayo Clinic
 (1.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Primary Objectives: Dose Escalation Part A: To determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory multiple myeloma (RRMM), and determine the recommended Phase 2 dose (RP2D) for the subsequent Expansion Part B Dose Expansion Part B: To assess the …

pomalidomide
lenalidomide
measurable disease
ixazomib
line of therapy
Investigational Site Number 8400005
 (1.8 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +7 other locations
None

Mayo Clinic Rochester
 (1.8 away) Contact site
  • 0 views
  • 19 May, 2025
  • +12 other locations
None

Mayo Clinic Rochester
 (1.8 away) Contact site
  • 0 views
  • 19 May, 2025
  • +13 other locations
AIM1: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid

There is an epidemic of thyroid cancer that is harmful to patients and the medical system. The study hypothesizes that the use of an electronic conversation aid during clinical visits can help patients and clinicians collaborate when deciding the next step in management for a thyroid nodule. The study aims …

thyroid nodule
thyroid biopsy
aim1
cancer
Mayo Clinic
 (1.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
A Study of CC-98633 BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed and/or Refractory Multiple Myeloma

This is a Phase 1, multicenter, open-label study of CC-98633, BCMA-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in subjects with relapsed and/or refractory multiple myeloma. The study will consist of 2 parts: dose-escalation (Part A) and dose-expansion (Part B). The dose-escalation part (Part A) of the study is to …

pomalidomide
refractory multiple myeloma
lenalidomide
immunotherapeutic agent
measurable disease
Mayo Clinic
 (1.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +8 other locations
Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery

The overarching goal of the study is to improve the surgical treatment outcomes of FAI, which is affecting an increasing number of military personnel and young active individuals in the general population. The proposed study will investigate critical patient, disease, and surgical treatment predictors of FAI surgery outcomes.

hip arthroscopy
arthroscopy
conservative management
femoroacetabular impingement
Mayo Clinic
 (5.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +11 other locations